GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

VIP peptides [Cleaved into: Intestinal peptide PHV-42 (Peptide histidine valine 42); Intestinal peptide PHM-27 (Peptide histidine methioninamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)]

 VIP_HUMAN               Reviewed;         170 AA.
P01282; Q5TCY8; Q5TCY9; Q96QK3;
21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
21-JUL-1986, sequence version 1.
13-FEB-2019, entry version 188.
RecName: Full=VIP peptides;
Contains:
RecName: Full=Intestinal peptide PHV-42;
AltName: Full=Peptide histidine valine 42;
Contains:
RecName: Full=Intestinal peptide PHM-27;
AltName: Full=Peptide histidine methioninamide 27;
Contains:
RecName: Full=Vasoactive intestinal peptide;
Short=VIP;
AltName: Full=Vasoactive intestinal polypeptide;
Flags: Precursor;
Name=VIP;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=6571696; DOI=10.1038/304547a0;
Itoh N., Obata K., Yanaihara N., Okamoto H.;
"Human preprovasoactive intestinal polypeptide contains a novel PHI-
27-like peptide, PHM-27.";
Nature 304:547-549(1983).
[2]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=3899557;
Tsukada T., Horovitch S.J., Montminy M.R., Mandel G., Goodman R.H.;
"Structure of the human vasoactive intestinal polypeptide gene.";
DNA 4:293-300(1985).
[3]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
PubMed=2995945; DOI=10.1016/0196-9781(85)90016-6;
Delamarter J.F., Buell G.N., Kawashima E., Polak J.M., Bloom S.R.;
"Vasoactive intestinal peptide: expression of the prohormone in
bacterial cells.";
Peptides 6 Suppl. 1:95-102(1985).
[4]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=3025882; DOI=10.1073/pnas.84.2.605;
Linder S., Barkhem T., Norberg A., Persson H., Schalling M.,
Hoekfelt T., Magnusson G.;
"Structure and expression of the gene encoding the vasoactive
intestinal peptide precursor.";
Proc. Natl. Acad. Sci. U.S.A. 84:605-609(1987).
[5]
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=2839091; DOI=10.1111/j.1749-6632.1988.tb26975.x;
Yamagami T., Ohsawa K., Nishizawa M., Inoue C., Gotoh E.,
Yanaihara N., Yamamoto H., Okamoto H.;
"Complete nucleotide sequence of human vasoactive intestinal
peptide/PHM-27 gene and its inducible promoter.";
Ann. N. Y. Acad. Sci. 527:87-102(1988).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
PubMed=14574404; DOI=10.1038/nature02055;
Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
"The DNA sequence and analysis of human chromosome 6.";
Nature 425:805-811(2003).
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
TISSUE=Prostate;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA
project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[8]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 8-170, AND AMIDATION AT MET-107
AND ASN-152.
PubMed=3748844; DOI=10.1016/0196-9781(86)90156-7;
Gozes I., Bodener M., Shani Y., Fridkin M.;
"Structure and expression of the vasoactive intestinal peptide (VIP)
gene in a human tumor.";
Peptides 7:1-6(1986).
[9]
NUCLEOTIDE SEQUENCE [MRNA] OF 50-170 (ISOFORM 1).
TISSUE=Pancreatic carcinoma;
PubMed=6139527; DOI=10.1016/S0140-6736(83)91215-1;
Bloom S.R., Delamarter J.F., Kawashima E., Christofides N.D.,
Buell G., Polak J.M.;
"Diarrhoea in vipoma patients associated with cosecretion of a second
active peptide (peptide histidine isoleucine) explained by single
coding gene.";
Lancet 2:1163-1165(1983).
[10]
NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 78-155.
PubMed=2434617; DOI=10.1111/j.1471-4159.1987.tb05638.x;
Gozes I., Giladi E., Shani Y.;
"Vasoactive intestinal peptide gene: putative mechanism of information
storage at the RNA level.";
J. Neurochem. 48:1136-1141(1987).
[11]
PROTEIN SEQUENCE OF 81-122.
PubMed=3654650;
Yiangou Y., di Marzo V., Spokes R.A., Panico M., Morris H.R.,
Bloom S.R.;
"Isolation, characterization, and pharmacological actions of peptide
histidine valine 42, a novel prepro-vasoactive intestinal peptide-
derived peptide.";
J. Biol. Chem. 262:14010-14013(1987).
[12]
PROTEIN SEQUENCE OF 127-152.
TISSUE=Pheochromocytoma;
PubMed=1318039; DOI=10.1016/S0006-291X(05)80966-0;
Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Matsuo H., Eto T.;
"Isolation and characterization of peptides which act on rat
platelets, from a pheochromocytoma.";
Biochem. Biophys. Res. Commun. 185:134-141(1992).
[13]
FUNCTION (PHM-27).
PubMed=15013843; DOI=10.1016/j.bcp.2003.11.008;
Ma J.N., Currier E.A., Essex A., Feddock M., Spalding T.A., Nash N.R.,
Brann M.R., Burstein E.S.;
"Discovery of novel peptide/receptor interactions: identification of
PHM-27 as a potent agonist of the human calcitonin receptor.";
Biochem. Pharmacol. 67:1279-1284(2004).
[14]
STRUCTURE BY NMR OF VIP.
PubMed=1863695; DOI=10.1002/bip.360310411;
Theriault Y., Boulanger Y., St Pierre S.;
"Structural determination of the vasoactive intestinal peptide by two-
dimensional H-NMR spectroscopy.";
Biopolymers 31:459-464(1991).
-!- FUNCTION: VIP causes vasodilation, lowers arterial blood pressure,
stimulates myocardial contractility, increases glycogenolysis and
relaxes the smooth muscle of trachea, stomach and gall bladder.
{ECO:0000269|PubMed:15013843}.
-!- FUNCTION: PHM and PHV also cause vasodilation. PHM-27 is a potent
agonist of the calcitonin receptor CALCR, with similar efficacy as
calcitonin. {ECO:0000269|PubMed:15013843}.
-!- INTERACTION:
P27487:DPP4; NbExp=2; IntAct=EBI-751454, EBI-2871277;
Q12884:FAP; NbExp=2; IntAct=EBI-751454, EBI-4319803;
O43765:SGTA; NbExp=3; IntAct=EBI-751454, EBI-347996;
P32241:VIPR1; NbExp=2; IntAct=EBI-6656819, EBI-3917984;
-!- SUBCELLULAR LOCATION: Secreted.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=2;
Name=1;
IsoId=P01282-1; Sequence=Displayed;
Name=2;
IsoId=P01282-2; Sequence=VSP_023256;
-!- SIMILARITY: Belongs to the glucagon family. {ECO:0000305}.
-!- WEB RESOURCE: Name=Wikipedia; Note=Vasoactive intestinal peptide
entry;
URL="https://en.wikipedia.org/wiki/Vasoactive_intestinal_peptide";
-----------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
-----------------------------------------------------------------------
EMBL; L00157; AAA61289.1; -; Genomic_DNA.
EMBL; L00154; AAA61289.1; JOINED; Genomic_DNA.
EMBL; L00155; AAA61289.1; JOINED; Genomic_DNA.
EMBL; L00156; AAA61289.1; JOINED; Genomic_DNA.
EMBL; M11553; AAA61284.1; -; Genomic_DNA.
EMBL; M11549; AAA61284.1; JOINED; Genomic_DNA.
EMBL; M11550; AAA61284.1; JOINED; Genomic_DNA.
EMBL; M11551; AAA61284.1; JOINED; Genomic_DNA.
EMBL; M11552; AAA61284.1; JOINED; Genomic_DNA.
EMBL; M36634; AAA61287.1; -; mRNA.
EMBL; M14623; AAA61288.1; -; Genomic_DNA.
EMBL; M14619; AAA61288.1; JOINED; Genomic_DNA.
EMBL; M14620; AAA61288.1; JOINED; Genomic_DNA.
EMBL; M14621; AAA61288.1; JOINED; Genomic_DNA.
EMBL; M14622; AAA61288.1; JOINED; Genomic_DNA.
EMBL; M33027; AAA69515.1; -; Genomic_DNA.
EMBL; AL133356; -; NOT_ANNOTATED_CDS; Genomic_DNA.
EMBL; BC009794; AAH09794.1; -; mRNA.
EMBL; M36610; AAA61286.1; -; Genomic_DNA.
EMBL; M36606; AAA61286.1; JOINED; Genomic_DNA.
EMBL; M36607; AAA61286.1; JOINED; Genomic_DNA.
EMBL; M36608; AAA61286.1; JOINED; Genomic_DNA.
EMBL; M36609; AAA61286.1; JOINED; Genomic_DNA.
EMBL; M54930; AAA63268.1; -; mRNA.
EMBL; M32162; AAA61285.1; -; Genomic_DNA.
EMBL; M31645; AAA61285.1; JOINED; Genomic_DNA.
CCDS; CCDS5240.1; -. [P01282-1]
CCDS; CCDS5241.1; -. [P01282-2]
PIR; A23296; VRHU.
RefSeq; NP_003372.1; NM_003381.3. [P01282-1]
RefSeq; NP_919416.1; NM_194435.2. [P01282-2]
UniGene; Hs.53973; -.
PDB; 2RRH; NMR; -; A=125-153.
PDB; 2RRI; NMR; -; A=125-153.
PDBsum; 2RRH; -.
PDBsum; 2RRI; -.
ProteinModelPortal; P01282; -.
SMR; P01282; -.
BioGrid; 113273; 9.
IntAct; P01282; 9.
MINT; P01282; -.
STRING; 9606.ENSP00000356213; -.
ChEMBL; CHEMBL5737; -.
iPTMnet; P01282; -.
PhosphoSitePlus; P01282; -.
BioMuta; VIP; -.
DMDM; 138574; -.
jPOST; P01282; -.
PaxDb; P01282; -.
PeptideAtlas; P01282; -.
PRIDE; P01282; -.
ProteomicsDB; 51368; -.
ProteomicsDB; 51369; -. [P01282-2]
DNASU; 7432; -.
Ensembl; ENST00000367243; ENSP00000356212; ENSG00000146469. [P01282-2]
Ensembl; ENST00000367244; ENSP00000356213; ENSG00000146469. [P01282-1]
GeneID; 7432; -.
KEGG; hsa:7432; -.
UCSC; uc003qpe.6; human. [P01282-1]
CTD; 7432; -.
DisGeNET; 7432; -.
EuPathDB; HostDB:ENSG00000146469.12; -.
GeneCards; VIP; -.
HGNC; HGNC:12693; VIP.
HPA; CAB018649; -.
HPA; HPA017324; -.
HPA; HPA072701; -.
MIM; 192320; gene.
neXtProt; NX_P01282; -.
OpenTargets; ENSG00000146469; -.
PharmGKB; PA37312; -.
eggNOG; ENOG410IW68; Eukaryota.
eggNOG; ENOG4111JKK; LUCA.
GeneTree; ENSGT00940000158495; -.
HOGENOM; HOG000253943; -.
HOVERGEN; HBG018069; -.
InParanoid; P01282; -.
KO; K05264; -.
OMA; FSHTLAW; -.
OrthoDB; 1343108at2759; -.
PhylomeDB; P01282; -.
TreeFam; TF332804; -.
Reactome; R-HSA-418555; G alpha (s) signalling events.
Reactome; R-HSA-420092; Glucagon-type ligand receptors.
SIGNOR; P01282; -.
EvolutionaryTrace; P01282; -.
GeneWiki; Vasoactive_intestinal_peptide; -.
GenomeRNAi; 7432; -.
PRO; PR:P01282; -.
Proteomes; UP000005640; Chromosome 6.
Bgee; ENSG00000146469; Expressed in 127 organ(s), highest expression level in fundus of stomach.
ExpressionAtlas; P01282; baseline and differential.
Genevisible; P01282; HS.
GO; GO:0005576; C:extracellular region; TAS:Reactome.
GO; GO:0043005; C:neuron projection; IBA:GO_Central.
GO; GO:0043204; C:perikaryon; IBA:GO_Central.
GO; GO:0005179; F:hormone activity; IDA:BHF-UCL.
GO; GO:0005184; F:neuropeptide hormone activity; IBA:GO_Central.
GO; GO:0051428; F:peptide hormone receptor binding; IPI:GO_Central.
GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:BHF-UCL.
GO; GO:0019731; P:antibacterial humoral response; IDA:UniProtKB.
GO; GO:0019732; P:antifungal humoral response; IDA:UniProtKB.
GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IDA:UniProtKB.
GO; GO:0007589; P:body fluid secretion; TAS:ProtInc.
GO; GO:0050829; P:defense response to Gram-negative bacterium; IDA:UniProtKB.
GO; GO:0050830; P:defense response to Gram-positive bacterium; IDA:UniProtKB.
GO; GO:0048242; P:epinephrine secretion; IBA:GO_Central.
GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:Reactome.
GO; GO:0045087; P:innate immune response; IDA:UniProtKB.
GO; GO:0007611; P:learning or memory; IBA:GO_Central.
GO; GO:0048255; P:mRNA stabilization; ISS:AgBase.
GO; GO:0043066; P:negative regulation of apoptotic process; IBA:GO_Central.
GO; GO:0043267; P:negative regulation of potassium ion transport; IBA:GO_Central.
GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IBA:GO_Central.
GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
GO; GO:0097755; P:positive regulation of blood vessel diameter; IBA:GO_Central.
GO; GO:0008284; P:positive regulation of cell population proliferation; TAS:ProtInc.
GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IBA:GO_Central.
GO; GO:0032812; P:positive regulation of epinephrine secretion; IBA:GO_Central.
GO; GO:0060406; P:positive regulation of penile erection; IBA:GO_Central.
GO; GO:0045732; P:positive regulation of protein catabolic process; IDA:BHF-UCL.
GO; GO:0070459; P:prolactin secretion; ISS:AgBase.
GO; GO:0032880; P:regulation of protein localization; IDA:BHF-UCL.
GO; GO:0051930; P:regulation of sensory perception of pain; IBA:GO_Central.
GO; GO:0001878; P:response to yeast; IDA:UniProtKB.
InterPro; IPR000532; Glucagon_GIP_secretin_VIP.
InterPro; IPR015523; VIP.
PANTHER; PTHR11213:SF5; PTHR11213:SF5; 1.
Pfam; PF00123; Hormone_2; 2.
SMART; SM00070; GLUCA; 2.
PROSITE; PS00260; GLUCAGON; 2.
1: Evidence at protein level;
3D-structure; Alternative splicing; Amidation;
Cleavage on pair of basic residues; Complete proteome;
Direct protein sequencing; Hormone; Phosphoprotein;
Reference proteome; Secreted; Signal.
SIGNAL 1 20 {ECO:0000255}.
PROPEP 21 79
/FTId=PRO_0000011457.
PEPTIDE 81 122 Intestinal peptide PHV-42.
/FTId=PRO_0000011458.
PEPTIDE 81 107 Intestinal peptide PHM-27.
/FTId=PRO_0000011459.
PEPTIDE 125 152 Vasoactive intestinal peptide.
/FTId=PRO_0000011460.
PROPEP 156 170
/FTId=PRO_0000011461.
MOD_RES 76 76 Phosphoserine.
{ECO:0000250|UniProtKB:P01283}.
MOD_RES 107 107 Methionine amide.
{ECO:0000269|PubMed:3748844}.
MOD_RES 152 152 Asparagine amide.
{ECO:0000269|PubMed:3748844}.
VAR_SEQ 113 113 Missing (in isoform 2).
{ECO:0000303|PubMed:15489334}.
/FTId=VSP_023256.
CONFLICT 96 97 QL -> PP (in Ref. 8; AAA61286).
{ECO:0000305}.
CONFLICT 116 116 S -> L (in Ref. 4; AAA61288).
{ECO:0000305}.
CONFLICT 136 136 R -> G (in Ref. 4; AAA61288).
{ECO:0000305}.
HELIX 128 152 {ECO:0000244|PDB:2RRH}.
SEQUENCE 170 AA; 19169 MW; 93EC0177F89508FD CRC64;
MDTRNKAQLL VLLTLLSVLF SQTSAWPLYR APSALRLGDR IPFEGANEPD QVSLKEDIDM
LQNALAENDT PYYDVSRNAR HADGVFTSDF SKLLGQLSAK KYLESLMGKR VSSNISEDPV
PVKRHSDAVF TDNYTRLRKQ MAVKKYLNSI LNGKRSSEGE SPDFPEELEK


Related products :

Catalog number Product name Quantity
SCH-PEPA41T RABBIT ANTI PIG VASOACTIVE INTESTINAL PEPTIDE, Product Type Polyclonal Antibody, Specificity VASOACTIVE INTESTINAL PEPTIDE, Target Species Pig, Host Rabbit, Format Serum, Isotypes Polyclonal IgG 20 µl
PEPA41T RABBIT ANTI PIG VASOACTIVE INTESTINAL PEPTIDE, Product Type Polyclonal Antibody, Specificity VASOACTIVE INTESTINAL PEPTIDE, Target Species Pig, Host Rabbit, Format Serum, Isotypes Polyclonal IgG 20 µl
SCH-9535-0204 RABBIT ANTI VASOACTIVE INTESTINAL PEPTIDE, Product Type Polyclonal Antibody, Specificity VASOACTIVE INTESTINAL PEPTIDE, Target Species Human, Host Rabbit, Format Purified, Isotypes Polyclonal Ig 0.5 ml
9535-0204 RABBIT ANTI VASOACTIVE INTESTINAL PEPTIDE, Product Type Polyclonal Antibody, Specificity VASOACTIVE INTESTINAL PEPTIDE, Target Species Human, Host Rabbit, Format Purified, Isotypes Polyclonal Ig 0.5 ml
orb72032 Vasoactive Intestinal peptide This is Vasoactive Intestinal peptide. For research use only. 1 mg
AE6302AG.1 Vasoactive Intestinal Peptide-Receptor 2 (VIP-R2) antigen: human Vasoactive Intestinal Peptide-Receptor 2 100
AE6302AG.2 Vasoactive Intestinal Peptide-Receptor 2 (VIP-R2) antigen: human Vasoactive Intestinal Peptide-Receptor 2 1 mg
U0380c CLIA Canis familiaris,Canis lupus familiaris,Dog,Vasoactive intestinal peptide,Vasoactive intestinal polypeptide,VIP,VIP 96T
E0380c ELISA Canis familiaris,Canis lupus familiaris,Dog,Vasoactive intestinal peptide,Vasoactive intestinal polypeptide,VIP,VIP 96T
E0380c ELISA kit Canis familiaris,Canis lupus familiaris,Dog,Vasoactive intestinal peptide,Vasoactive intestinal polypeptide,VIP,VIP 96T
orb72033 Vasoactive Intestinal Constractor [VIC] peptide This is Vasoactive Intestinal Constractor [VIC] peptide. For research use only. 1 mg
orb72031 Vasoactive Intestinal Contractor [VIC] peptide This is Vasoactive Intestinal Contractor [VIC] peptide. For research use only. 1 mg
VIPR11-P Mouse Vasoactive intestinal peptide receptor (VIPR1_VPAC1) Control_blocking peptide 1 100 ug
064-10 Vasoactive Intestinal Peptide (VIP)(PHM)(111_122) _Prepro (PHM_VIP Space Peptide) _ 500ug 500 µg
AE6302AG.2 human Vasoactive Intestinal Peptide-Receptor 2 form: Synthetic peptide 1 mg
AE6302AG.1 human Vasoactive Intestinal Peptide-Receptor 2 form: Synthetic peptide 100
VIPR21-P Rat Vasoactive intestinal peptide receptor (VIPR2_VPAC2) Control_blocking peptide 1 100 ug
VIP16-P Mouse Vasoactive intestinal peptide (VIP) Control blocking peptide #1 100 ug
VIPR21-P Rat Vasoactive intestinal peptide receptor (VIPR2 VPAC2) Control blocking peptide #1 100 ug
VIPRRP11-P Rat Vasoactive intestinal peptide receptor_gene repressor protein (VIPRRP) Control_blocking peptide 1 100 ug
VIPR11-P Mouse Vasoactive intestinal peptide receptor (VIPR1 VPAC1) Control blocking peptide #1 100 ug
VIP16-P Mouse Vasoactive intestinal peptide (VIP) Control_blocking peptide 1 100 ug
VIPRRP11-P Rat Vasoactive intestinal peptide receptor-gene repressor protein (VIPRRP) Control blocking peptide #1 100 ug
5-43234 Vasoactive Intestinal peptide, peptide reagents 1 mg
5-43235 Vasoactive Intestinal peptide, peptide reagents 2.5 mg

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Gentaur; yes we can

Pathways :
WP1001: Peptide GPCRs
WP1117: Peptide GPCRs
WP131: Peptide GPCRs
WP1338: Peptide GPCRs
WP234: Peptide GPCRs
WP24: Peptide GPCRs
WP771: Peptide GPCRs
WP883: Peptide GPCRs
WP1581: Histidine metabolism
WP2185: Purine metabolism
WP416: Superpathway of Histidine, Purine, and Pyrimidine
WP514: Histidine Biosynthesis
WP1451: Valine, leucine and isoleucine degradation
WP1716: Valine, leucine and isoleucine biosynthesis
WP1717: Valine, leucine and isoleucine degradation
WP198: Isoleucine, Leucine, and Valine biosynthesis
WP2: Valine Biosynthesis
WP359: Isoleucine and Valine biosynthesis

Related Genes :
[VIP] VIP peptides [Cleaved into: Intestinal peptide PHV-42 (Peptide histidine valine 42); Intestinal peptide PHM-27 (Peptide histidine methioninamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)]
[Vip] VIP peptides [Cleaved into: Intestinal peptide PHV-42; Intestinal peptide PHI-27 (Peptide histidine isoleucinamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)]
[Vip] VIP peptides [Cleaved into: Intestinal peptide PHI-42; Intestinal peptide PHI-27 (Peptide histidine isoleucinamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)]
[VIP] VIP peptides [Cleaved into: Intestinal peptide PHI-27 (Peptide histidine isoleucinamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)] (Fragment)
[VIP] VIP peptides [Cleaved into: Intestinal peptide PHI-27 (Peptide histidine isoleucinamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)]
[VIP] VIP peptides [Cleaved into: Intestinal peptide PHI-27-like; Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)]
[VIPR1] Vasoactive intestinal polypeptide receptor 1 (VIP-R-1) (Pituitary adenylate cyclase-activating polypeptide type II receptor) (PACAP type II receptor) (PACAP-R-2) (PACAP-R2) (VPAC1)
[GCG] Glucagon [Cleaved into: Glicentin; Glicentin-related polypeptide (GRPP); Oxyntomodulin (OXM) (OXY); Glucagon; Glucagon-like peptide 1 (GLP-1) (Incretin hormone); Glucagon-like peptide 1(7-37) (GLP-1(7-37)); Glucagon-like peptide 1(7-36) (GLP-1(7-36)); Glucagon-like peptide 2 (GLP-2)]
[] Bradykinin-potentiating and C-type natriuretic peptides (Brain BPP-CNP) (bBPP-CNP) (Evasin-CNP) [Cleaved into: Bradykinin-potentiating peptide 13a+QQWA (BPP-13a+QQWA); Bradykinin-potentiating peptide 13a+QWA (BPP-13a+QWA); Bradykinin-potentiating peptide 13a (BPP-13a); Bradykinin-potentiating peptide 10c+QQWA (BPP-10c+QQWA); Bradykinin-potentiating peptide 10c (BPP-10c) (BPP-2) (Evasin-10c); Bradykinin-potentiating peptide 12b (BPP-12b) (Evasin-12b); Bradykinin-potentiating peptide AP; Bradykinin-potentiating peptide APL (BPP-APL); Bradykinin-potentiating peptide 11e (BPP-11e) (Evasin-11e); Bradykinin-potentiating peptide 5a (BPP-5a) (Bradykinin-potentiating peptide Va) (BPPVa) (Evasin-5a) (Proline-rich peptide 5a) (Bj-PRO-5a) (PRO-5a); Poly-His-poly-Gly peptide 1 (pHpG-1); C-type natriuretic peptide (Bj-CNP)]
[] Bradykinin-potentiating and C-type natriuretic peptides (BPP-CNP) [Cleaved into: Bradykinin-potentiating peptide 6a (BPP-6a); Bradykinin-potentiating peptide 10a (BPP-10a) (Bradykinin-potentiating peptide IV-1-A) (BPPIV-1-A) (Bradykinin-potentiating peptide V-8); Bradykinin-potentiating peptide 13a+QQWA (BPP-13a+QQWA); Bradykinin-potentiating peptide 13a+QWA (BPP-13a+QWA); Bradykinin-potentiating peptide 13a (BPP-13a) (Bradykinin-potentiating peptide III-1-A) (III-1-A) (Bradykinin-potentiating peptide V-9); Bradykinin-potentiating peptide 10c+QQWA (BPP-10c+QQWA); Bradykinin-potentiating peptide 10c (BPP-10c) (BPP-2) (Bradykinin-potentiating peptide IV-1-Bbeta) (BPP IV-1-Bbeta) (Bradykinin-potentiating peptide V-7); Bradykinin-potentiating peptide 10c-F (BPP-10c-F); Bradykinin-potentiating peptide 11b (BPP-11b) (Bradykinin-potentiating peptide IIa) (BPP-IIa); Bradykinin-potentiating peptide IIb (BPP-IIb); Bradykinin-potentiating peptide 5a (BPP-5a) (Bradykinin-potentiating peptide Va) (BPPVa) (Proline-rich peptide 5a) (Bj-PRO-5a) (PRO-5a); Poly-His-poly-Gly peptide 1 (pHpG-1); C-type natriuretic peptide (Bj-CNP)]
[] Bradykinin-potentiating and C-type natriuretic peptides (Angiotensin-converting enzyme inhibitor) (BPP-CNP homolog) [Cleaved into: Bradykinin-potentiating peptide 13a (BPP-13a) (Bradykinin-potentiating peptide S3,1); Bradykinin-potentiating peptide 10c (BPP-10c) (BPP-2) (Bradykinin-potentiating peptide S4,3,1); Bradykinin-potentiating peptide 12b (BPP-12b) (Bradykinin-potentiating peptide S4,3,2); Bradykinin-potentiating peptide 11e (BPP-11e); Bradykinin-potentiating peptide 5a (BPP-5a) (Bradykinin-potentiating peptide S5,2) (Bradykinin-potentiating peptide Va) (BPPVa) (Proline-rich peptide 5a) (PRO-5a); C-type natriuretic peptide (CNP)]
[] Bradykinin-potentiating and C-type natriuretic peptides (BPP-CNP) [Cleaved into: Bradykinin-potentiating peptide 1 (BPP 1); Bradykinin-potentiating peptide 2 (BPP 2); Bradykinin-potentiating peptide 3 (BPP 3); Bradykinin-potentiating peptide 4 (BPP 4); Bradykinin-potentiating peptide 5 (BPP 5); Bradykinin inhibitor peptide (BIP); C-type natriuretic peptide (CNP)]
[] Bradykinin-potentiating and C-type natriuretic peptides (Angiotensin-converting enzyme inhibitor) (BPP-CNP homolog) [Cleaved into: Blomhotin; Bradykinin-potentiating peptide A (BPP-a) (Potentiator A); Leu3-blomhotin (Potentiator D); Bradykinin-potentiating peptide B (BPP-b) (Potentiator B); Bradykinin-potentiating peptide C (BPP-c) (Potentiator C); Bradykinin-potentiating peptide E (BPP-e) (Potentiator E); Bradykinin-potentiating peptide Ahb1 (BPP-Ahb1); Bradykinin-potentiating peptide Ahb2 (BPP-Ahb2); C-type natriuretic peptide]
[GUCY2C GUC2C STAR] Heat-stable enterotoxin receptor (STA receptor) (hSTAR) (EC 4.6.1.2) (Guanylyl cyclase C) (GC-C) (Intestinal guanylate cyclase)
[TFF3 ITF TFI] Trefoil factor 3 (Intestinal trefoil factor) (hITF) (Polypeptide P1.B) (hP1.B)
[APP A4 AD1] Amyloid-beta precursor protein (APP) (ABPP) (APPI) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31]
[gag] Gag polyprotein [Cleaved into: Matrix protein p19; p2A; p2B; p10; Capsid protein p27, alternate cleaved 1; Capsid protein p27, alternate cleaved 2; Spacer peptide (SP) (p3); Nucleocapsid protein p12; Protease p15 (EC 3.4.23.-)]
[GCG] Glucagon [Cleaved into: Glicentin-related polypeptide (GRPP); Glucagon; Glucagon-like peptide 1 (GLP-1); Glucagon-like peptide 1(7-37) (GLP-1(7-37)); Glucagon-like peptide 1(7-36) (GLP-1(7-36)); Glucagon-like peptide 2 (GLP-2)]
[gag-pol] Gag-Pol polyprotein [Cleaved into: Matrix protein p19; p2A; p2B; p10; Capsid protein p27, alternate cleaved 1; Capsid protein p27, alternate cleaved 2; Spacer peptide (SP) (p3); Nucleocapsid protein p12; Protease p15 (EC 3.4.23.-); Reverse transcriptase, beta-subunit (RT-beta); Reverse transcriptase, alpha-subunit (RT-alpha) (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4); Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-) (pp32); p4]
[GHRL MTLRP UNQ524/PRO1066] Appetite-regulating hormone (Growth hormone secretagogue) (Growth hormone-releasing peptide) (Motilin-related peptide) (Protein M46) [Cleaved into: Ghrelin-27; Ghrelin-28 (Ghrelin); Obestatin]
[VIP EGK_15243] VIP peptides isoform 1 preproprotein (Vasoactive intestinal peptide)
[HCS2] HCS2 neuropeptides (CNP neuropeptides) (Command neuron-specific peptides) [Cleaved into: Peptide CNP1 (CNP1); Peptide CNP2 (CNP2) (DYPRLamide); Peptide CNP3 (CNP3); Peptide CNP4 (CNP4)]
[vip] Vasoactive intestinal peptide
[HTN1 HIS1] Histatin-1 (Histidine-rich protein 1) (Post-PB protein) (PPB) [Cleaved into: His1-(31-57)-peptide (His1 31/57) (His1-(12-38)-peptide) (His1 12/38) (Histatin-2)]
[MUC17 MUC3] Mucin-17 (MUC-17) (Small intestinal mucin-3) (MUC-3)
[] Snake venom metalloprotease inhibitor 02D01 (02E11) (10F07) (Svmpi-Eoc7) [Cleaved into: Tripeptide pEKW 1; Tripeptide pEKW 2; Tripeptide pEKW 3; Tripeptide pEKW 4; Tripeptide pEKW 5; Tripeptide pEKW 6; Tripeptide pEKW 7; Tripeptide pEKW 8; Tripeptide pEKW 9; Tripeptide pEKW 10; Tripeptide pEKW 11; Poly-His-poly-Gly peptide 4 (pHpG-4); Poly-His-poly-Gly peptide 3 (pHpG-3); Poly-His-poly-Gly peptide 2 (pHpG-2); Poly-His-poly-Gly peptide 1 (pHpG-1); C-type natriuretic peptide (CNP)]
[vip] Histidine-isoleucine/vasoactive intestinal polypeptide
[Atk TK] Tachykinins (AmTRP) (Tachykinin-related peptide) [Cleaved into: APTGHQEMQ-amide (AmTRP1) (Tachykinin-related peptide 1) (TRP1); ALMGFQGVR-amide (AmTRP2) (Tachykinin-related peptide 2) (TRP2); Brain peptide NSIINDVKNELFPEDIN; APMGFQGMR-amide 1 (AmTRP3) (Tachykinin-related peptide 3-1) (TRP3-1); Brain peptide ASFDDEYY; APMGFQGMR-amide 2 (AmTRP3) (Tachykinin-related peptide 3-2) (TRP3-2); Brain peptide SLEEILDEIK; Brain peptide SLEEILDEI; Brain peptide EILDEI; TTRFQDSRSKDVYLIDYPEDY-amide (AmTAP1) (Tachykinin-associated peptide 1); Brain peptide VLSMDGYQNILDKKDELLGEWE; Brain peptide APMGFYGT; APMGFYGTR-amide (AmTRP4) (Tachykinin-related peptide 4) (TRP4); Brain peptide IILDALEELD; Brain peptide ILDALEELD; Brain peptide GVMDFQIGLQ; ARMGFHGMR-amide (AmTRP5) (Tachykinin-related peptide 5) (TRP5); SPFRYLGAR-amide (AmTRP6) (Tachykinin-related peptide 6) (TRP6); NPRWEFRGKFVGVR-amide (AmTRP7) (Tachykinin-related peptide 7) (TRP7)]
[Tk CG14734] Tachykinins (dTk) [Cleaved into: Tachykinin-related peptide 1 (TK-1) (dTK-1) (APTSSFIGMR-amide); Tachykinin-associated peptide 1 (TAP1) (DEEHDTSEGNWLGSGPDPLDYADEEADSSYAEN-amide); Tachykinin-related peptide 2 (TK-2) (dTK-2) (APLAFVGLR-amide); Tachykinin-associated peptide 2 (TAP2) (FIPINNRLSDVLQSLEEERLRDSLLQDFFDRVAGRDGSAV-amide); Tachykinin-related peptide 3 (TK-3) (dTK-3) (APTGFTGMR-amide); Tachykinin-associated peptide 3 (TAP3) (Brain peptide PALLAGDDDAEADEATELQQ); Tachykinin-related peptide 4 (TK-4) (dTK-4) (APVNSFVGMR-amide); Tachykinin-associated peptide 4 (TAP4) (Brain peptide DVSHQHY); Tachykinin-associated peptide 5 (TAP5) (AALSDSYDLRGKQQRFADFNSKFVAVR-amide); Tachykinin-associated peptide 6 (TAP6) (Brain peptide SDLEGNGVGIGDDHEQALVHPWLYLWGE); Tachykinin-related peptide 5 (TK-5) (dTK-5) (APNGFLGMR-amide)]
[gag] Gag polyprotein [Cleaved into: Matrix protein p19; p2A; p2B; p10; Capsid protein p27, alternate cleaved 1; Capsid protein p27, alternate cleaved 2; Spacer peptide (SP) (p3); Nucleocapsid protein p12; Protease p15 (EC 3.4.23.-)]

Bibliography :
?>